How Much Weight Per Week Do You Lose on Semaglutide?

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by slowing stomach emptying and increasing feelings of fullness, leading to reduced calorie intake without extreme dietary restriction. Most patients experience noticeable weekly weight loss within the first four weeks of treatment, though the exact amount varies based on starting weight, baseline metabolism, and adherence to medication dosing. Understanding realistic expectations helps you stay motivated and recognize whether your body is responding as intended.

Typical Weekly Weight Loss Rates on Semaglutide

Clinical trials show that patients lose between 1 and 2 pounds per week during the initial titration phase, typically weeks 1 through 4. This rate tends to be faster in the first month because your body is adjusting to the appetite-suppressing effects and you are eating significantly fewer calories without hunger. Weight loss may slow slightly as weeks progress into month two and three, which is a normal biological response called a weight-loss plateau.

By the end of month one, many patients report a total loss of 4 to 8 pounds depending on their starting weight and metabolism. Heavier individuals often see larger absolute numbers in early weeks, while those with slower metabolisms may experience slightly more gradual progress. Consistency with your PlexusDx semaglutide injection schedule is the strongest predictor of sustained weekly results.

Cumulative Weight Loss After 3 Months of Semaglutide Treatment

After 12 weeks of steady semaglutide use, the average patient achieves 10 to 15 pounds of total weight loss, with some patients reaching 20 pounds or more depending on individual factors. This cumulative effect builds as your body maintains the appetite-suppressing response and you continue making calorie-conscious food choices. Three months is also when many patients begin to notice improved energy, better fitting clothes, and reduced cravings for high-sugar and high-fat foods.

The longer-term outcomes from semaglutide therapy extend well beyond three months; studies tracking patients for six months and beyond show cumulative losses of 20 to 30 pounds on average. Your specific results depend on dose escalation, lifestyle factors like exercise and sleep, and whether your genetics predispose you to stronger or milder responses to GLP-1 receptor activation—something PlexusDx can assess with the Precision Peptide Genetic Test.

Factors That Influence Your Individual Weekly Loss Amount

Your starting body weight significantly affects how much you lose per week; individuals over 250 pounds often experience faster initial losses than those closer to their target weight. Baseline metabolism, age, sex, and muscle mass all play measurable roles in determining the speed of weight reduction on semaglutide. Additionally, how strictly you adhere to reduced-calorie eating patterns and whether you exercise regularly will amplify or diminish the medication's effects.

Genetic factors also influence individual response to semaglutide therapy. Variations in the GLP1R and GIPR genes affect how sensitively your body responds to the medication, which can explain why one patient loses 2 pounds weekly while another loses 0.5 pounds weekly at the same dose. PlexusDx Precision Peptide Genetic Testing analyzes 14 pathways and 49 peptides to reveal your unique genetic predispositions, allowing your provider to choose the optimal starting dose and compound for your body.

How PlexusDx Semaglutide Dosing Maximizes Your Weekly Results

PlexusDx compounded semaglutide injections are prepared by licensed 503A compounding pharmacies and start at $149 per month with a flat price structure—your dose may need to go up over time, but your price won't. This pricing transparency lets you focus on finding the right therapeutic dose without worrying about unexpected cost increases as your provider adjusts your injection strength. Available in all 50 states with no insurance required, PlexusDx semaglutide is HSA and FSA eligible, making treatment accessible regardless of employment status.

Personalized dosing protocols are essential because one standard dose does not work equally well for everyone. Some patients reach optimal weight loss at 0.5 mg weekly, while others require 1.0 mg or 2.0 mg to achieve the same appetite suppression and weekly loss rate. Working with a PlexusDx provider ensures your injection dose is calibrated to your body's response, maximizing results while minimizing side effects like nausea or constipation.

Realistic Expectations Beyond the First Month

After the initial rapid weight loss phase, your weekly loss typically settles into a more gradual pattern of 0.5 to 1 pound per week, continuing steadily over months four through six. This slower rate is normal and healthy; your body has adapted to the appetite-suppressing mechanism and is now operating at a genuinely reduced calorie intake rather than a medication-induced shock to your system. Many patients find this steady, sustainable pace more psychologically manageable and less likely to trigger rapid rebound weight gain.

Long-term success on semaglutide depends on maintaining your dose and lifestyle changes even after reaching your goal weight. Research shows that stopping semaglutide typically leads to gradual weight regain, which is why many patients benefit from extended or indefinite use under medical supervision. PlexusDx providers can help you determine whether ongoing therapy or a lower maintenance dose makes sense for your specific goals and genetic profile.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is it normal to lose more than 2 pounds per week on semaglutide?

Losing more than 2 pounds weekly is less common but can occur in patients with higher starting weights or those combining semaglutide with structured exercise and calorie restriction. However, very rapid weight loss sometimes indicates inadequate calorie intake or underlying metabolic stress.

What does clinical trial data say about semaglutide weight loss timelines?

The STEP trials (Semaglutide Treatment Effect in People with obesity) showed that participants lost an average of 5 to 10 percent of their body weight by week 16, then continued losing through week 68. Patients on the 2.4 mg dose achieved the greatest losses, averaging 15 percent body weight reduction by the end of the study period.

Can PlexusDx help me predict my individual weight loss rate before starting?

Yes. PlexusDx Precision Peptide Genetic Testing analyzes key variants like GLP1R rs6923761 and GIPR rs1800437 that influence how strongly your body responds to semaglutide therapy.

What happens if I hit a weight-loss plateau after a few weeks?

Plateaus are common and temporary; your body is adapting to your lower calorie intake and the medication's effects.

Does PlexusDx offer other semaglutide forms if injections aren't right for me?

PlexusDx offers oral semaglutide starting at $249 per month for patients who prefer tablets to injections, with the same flat pricing guarantee. Oral semaglutide is absorbed through the stomach lining and produces similar weight loss results, though some patients report injections are more effective for appetite suppression.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Semaglutide For Weight Loss 2

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.